SlideShare a Scribd company logo
INFANT
       WITH
ACUTE LIVER FAILURE
1.5 months, male, born of non consanguineous
marriage, 1st by birth order, birth weight 2.9kg,
with h/o:

•Yellowish discoloration of eyes and skin since
3days

•Abdominal  distension with increased frequency
of stools since 2days

•Fever   since 1day
ON ENQUIRY:
    Child apparently alright 3 days back when he
    developed;

•  Yellowish discoloration of skin and eyes with
  high colored urine
• No clay colored stools.
• Abdominal distension progressively increasing
  leading to respiratory distress.
• Stool frequency 9-12 episodes of green
  stools/day
•   One episode of malena.
•   H/o fever, low to moderate grade for one day
•   No h/o prolonged neonatal jaundice,
•   No h/o seizures,
•   No h/o refusal to feed or decreased urinary
    output.

    Birth h/o: Uneventful

    Development h/o : Normal

    Family & Past history: Not significant
GENERAL EXAMINATION
Drowsy, afebrile;
HR=124/min, pulses well felt;
RR=58/min, subcostal retractions+;
SPO2=98 on room air
BP= 74/46 mmHg, HGT -30 mg/dl
Anthropometry: Weight -4.2 kg,10th centile,
                 Length -52cms, 5th centile.
Icterus+++,Pallor+,
No dysmorphic features.
No cataracts.
No skin changes.
SYSTEMIC EXAMINATION
P/A:
• Distended, dilated abdominal veins, umbilical
  hernia+,
• Liver 2cm, span 8 cm, firm, sharp margins,
  nontender.
• Spleen 3 cm,firm.
• Fluid thrill +
RS: Air entry b/l equal
CVS: S1S2 normal.
CNS : Drowsy,
       tone, reflexes normal.
IMPRESSION

  Hyperacute liver failure unlikely due to infection
  alone;
  D/D:
• In born error of metabolism precipitated by an
  infection.
• TORCH Infection – but no h/o antenatal illness or
  prematurity or IUGR, Normal at birth, until 3
  days before admission
INITIAL MANAGEMENT


•   O2 by hood
•   I.V Fluids to maintain Euglycemia
•   Blood Cultures collected
•   1st dose antibiotics given
•   Inj Vit K i.v
Day1            Day 2    Day 3    Day 4         Day 5    Day 6
Hb(g/dL)       6.8             5.5      7.6      5.1           7.3      7.0
TLC(/cumm      22,200          26,500   14,800   3,600         6,500    5,900
)
Plt(/cumm)     2.4L            2.18 L   1.3 L    40,000        38,000   25,000
s.Bili         38/14           32/23    24/6.1   23/4.5        17.2/5.7 17.6/3.6
T/D(mg/dl)
SGOT(IU/L) 306                 218      170      94            91       105
SGPT(IU/L)     94              144      100      44            42       40
s.Alb(g/dl)    3.2             2.4      2.6                    2.7
PT/PTT         78.7/>2 mins                      52.5/>2mins
RBS            30              131      28       142           60       62
ABG            7.46/13.5/18.            7.5/
(pH/Hco3/      6                        14.5/
pCO2)          Met Acidosis             18.1
               +Resp Alk
NH3            108                      188                    134
(micromol/l)
LDH(IU/L)                      2263
U.Red subs                     Trace    2+                     3+
FURTHER MANAGEMENT
        For Fulminant hepatic failure

 Started i.v NAC, i.v L-ornithine, L-aspartate,
    GDR(glucose delivery rate) increased,
    PRBC Transfusion, FFP Transfusion.

 Sensorium deteriorated with worsening LFTs,
  Hypoglycemia inspite of increasing GDR.

               Shifted to IPCU
Day1            Day 2    Day 3    Day 4         Day 5    Day 6
Hb(g/dL)       6.8             5.5      7.6      5.1           7.3      7.0
TLC(/cumm      22,200          26,500   14,800   3,600         6,500    5,900
)
Plt(/cumm)     2.4L            2.18 L   1.3 L    40,000        38,000   25,000
s.Bili         38/14           32/23    24/6.1   23/4.5        17.2/5.7 17.6/3.6
T/D(mg/dl)
SGOT(IU/L) 306                 218      170      94            91       105
SGPT(IU/L)     94              144      100      44            42       40
s.Alb(g/dl)    3.2             2.4      2.6                    2.7
PT/PTT         78.7/>2 mins                      52.5/>2mins
RBS            30              131      28       142           60       62
ABG            7.46/13.5/18.            7.5/
(pH/Hco3/      6                        14.5/
pCO2)          Met Acidosis             18.1
               +Resp Alk
NH3            108                      188                    134
(micromol/l)
LDH(IU/L)                      2263
U.Red subs                     Trace    2+                     3+
INVESTIGATIONS FOR
ETIOLOGICAL DIAGNOSIS


•SEPSIS CRP Negative,Blood Cultures
negative.

•TORCH   Titres  Negative

•HLH(Hemophagocytic     Lympho
Histiocytosis )
normal ferritin, bone marrow- no
hemophagocytes.
Ctd..
  •   IEM:
  TYROSINEMIA  AFP 400ng/ml (normal)

  GALACTOSEMIA 
  Urine Thin Layer Chromatography galactose+,
  Total Galactose High,
  GALT Enzyme level Low.
On 9th day—
Child developed increasing respiratory distress,
    Persistent hypoglycemia on GDR of 14,



            Intubated & ventilated..



        Child succumbed to his disease.
CONCLUSION
1.5 mnths old infant with
• Hyperacute liver failure
• Direct hyperbilirubinemia
• Persistent hypoglycemia inspite of high GDR.
• Metabolic Acidosis
• Urine Thin Layer Chromatography - Galactose+,
• Total Galactose High,
• GALT Enzyme level Low.
• Diagnosed as GALACTOSEMIA

More Related Content

What's hot

Glycogen storage disorder case presentation2
Glycogen storage disorder case presentation2Glycogen storage disorder case presentation2
Glycogen storage disorder case presentation2
Sanjeev Kumar
 
Paediatrics - Case presentation: fever+rash
Paediatrics - Case presentation: fever+rashPaediatrics - Case presentation: fever+rash
Paediatrics - Case presentation: fever+rash
patrickcouret
 

What's hot (20)

Newborn Screening
Newborn ScreeningNewborn Screening
Newborn Screening
 
Galactosemia
GalactosemiaGalactosemia
Galactosemia
 
Galactosemia LB
Galactosemia LBGalactosemia LB
Galactosemia LB
 
A quick revision of Carbohydrate metabolism with case- based discussions and ...
A quick revision of Carbohydrate metabolism with case- based discussions and ...A quick revision of Carbohydrate metabolism with case- based discussions and ...
A quick revision of Carbohydrate metabolism with case- based discussions and ...
 
Non ketotic hyperglycinemia
Non ketotic hyperglycinemiaNon ketotic hyperglycinemia
Non ketotic hyperglycinemia
 
Mucopolysaccharidoses
MucopolysaccharidosesMucopolysaccharidoses
Mucopolysaccharidoses
 
GLCOGEN STORAGE DISORDERS
GLCOGEN STORAGE DISORDERSGLCOGEN STORAGE DISORDERS
GLCOGEN STORAGE DISORDERS
 
Galactosemia
GalactosemiaGalactosemia
Galactosemia
 
Galactosemia
GalactosemiaGalactosemia
Galactosemia
 
Glycogen storage disorder case presentation2
Glycogen storage disorder case presentation2Glycogen storage disorder case presentation2
Glycogen storage disorder case presentation2
 
FABRY'S DISEASE.pdf
FABRY'S DISEASE.pdfFABRY'S DISEASE.pdf
FABRY'S DISEASE.pdf
 
Tay Sachs disease
Tay Sachs diseaseTay Sachs disease
Tay Sachs disease
 
Inborn Errors of Metabolism
Inborn Errors of MetabolismInborn Errors of Metabolism
Inborn Errors of Metabolism
 
Pompes disease
Pompes diseasePompes disease
Pompes disease
 
Inbornerrorsofmetabolism
InbornerrorsofmetabolismInbornerrorsofmetabolism
Inbornerrorsofmetabolism
 
G6pd
G6pdG6pd
G6pd
 
Inborn error of metabolism ( Prenatal & Newborn Screening )
Inborn error of metabolism ( Prenatal & Newborn Screening )Inborn error of metabolism ( Prenatal & Newborn Screening )
Inborn error of metabolism ( Prenatal & Newborn Screening )
 
Paediatrics - Case presentation: fever+rash
Paediatrics - Case presentation: fever+rashPaediatrics - Case presentation: fever+rash
Paediatrics - Case presentation: fever+rash
 
Krabbe Disease
Krabbe DiseaseKrabbe Disease
Krabbe Disease
 
Trophic feeding, by dr Amal Ahmed Khalil ,Port Said University,
Trophic feeding, by dr Amal Ahmed Khalil ,Port Said University, Trophic feeding, by dr Amal Ahmed Khalil ,Port Said University,
Trophic feeding, by dr Amal Ahmed Khalil ,Port Said University,
 

Viewers also liked

Hbs ag positive in special situation dr. prarthana kalgaonkar
Hbs ag positive in special situation   dr. prarthana kalgaonkarHbs ag positive in special situation   dr. prarthana kalgaonkar
Hbs ag positive in special situation dr. prarthana kalgaonkar
Sanjeev Kumar
 
Indirectly directed hyperbilirubinemia
Indirectly directed hyperbilirubinemiaIndirectly directed hyperbilirubinemia
Indirectly directed hyperbilirubinemia
Sanjeev Kumar
 
Iron and cancer talk k m mohandas
Iron and cancer talk k m mohandasIron and cancer talk k m mohandas
Iron and cancer talk k m mohandas
Sanjeev Kumar
 
Not to miss this puo
Not to miss this puoNot to miss this puo
Not to miss this puo
Sanjeev Kumar
 
Talk: Does hemochromatosis exist in india by Dr. Rakesh Aggarwal
Talk: Does hemochromatosis exist in india  by Dr. Rakesh AggarwalTalk: Does hemochromatosis exist in india  by Dr. Rakesh Aggarwal
Talk: Does hemochromatosis exist in india by Dr. Rakesh Aggarwal
Sanjeev Kumar
 

Viewers also liked (20)

Child with acute liver failure dr. kirtichandra kodali
Child with acute liver failure dr.  kirtichandra kodaliChild with acute liver failure dr.  kirtichandra kodali
Child with acute liver failure dr. kirtichandra kodali
 
Liver failure in an infant dr. vikrant sood
Liver failure in an infant    dr. vikrant soodLiver failure in an infant    dr. vikrant sood
Liver failure in an infant dr. vikrant sood
 
Acute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhalAcute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhal
 
2 neonatal liver failure
2 neonatal liver failure2 neonatal liver failure
2 neonatal liver failure
 
New kids in town 10 2013
New kids in town 10 2013New kids in town 10 2013
New kids in town 10 2013
 
Systemic illness with hepatitis dr ambreen pandrowala
Systemic illness with hepatitis dr ambreen pandrowalaSystemic illness with hepatitis dr ambreen pandrowala
Systemic illness with hepatitis dr ambreen pandrowala
 
15 month child with fatty liver dr. bikrant bihari lal
15 month child with fatty liver  dr.  bikrant bihari lal15 month child with fatty liver  dr.  bikrant bihari lal
15 month child with fatty liver dr. bikrant bihari lal
 
Hbs ag positive in special situation dr. prarthana kalgaonkar
Hbs ag positive in special situation   dr. prarthana kalgaonkarHbs ag positive in special situation   dr. prarthana kalgaonkar
Hbs ag positive in special situation dr. prarthana kalgaonkar
 
Thalassemia major with hepatitis c dr. ramya h n
Thalassemia major with hepatitis c   dr. ramya h nThalassemia major with hepatitis c   dr. ramya h n
Thalassemia major with hepatitis c dr. ramya h n
 
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meenaHepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
 
11 yr old with a fatty liver dr. shilpa hegde
11 yr old with a fatty liver  dr. shilpa hegde11 yr old with a fatty liver  dr. shilpa hegde
11 yr old with a fatty liver dr. shilpa hegde
 
Wilson’s disease – how do i manage dr. ashish bavdekar
Wilson’s disease – how do i manage dr. ashish  bavdekarWilson’s disease – how do i manage dr. ashish  bavdekar
Wilson’s disease – how do i manage dr. ashish bavdekar
 
Persistent jaundice a neonate dr. moinak sen sarma
Persistent jaundice a neonate  dr. moinak sen sarmaPersistent jaundice a neonate  dr. moinak sen sarma
Persistent jaundice a neonate dr. moinak sen sarma
 
Hepatitis in an hiv positive child dr. radhika kalekar
Hepatitis in an hiv positive child dr. radhika kalekarHepatitis in an hiv positive child dr. radhika kalekar
Hepatitis in an hiv positive child dr. radhika kalekar
 
Hepatitis b in children dr. anshu srivastava
Hepatitis b in children dr. anshu srivastavaHepatitis b in children dr. anshu srivastava
Hepatitis b in children dr. anshu srivastava
 
Common drug induced liver injury in children -dr. harshad devarbhai
Common drug induced liver injury in children -dr.  harshad devarbhaiCommon drug induced liver injury in children -dr.  harshad devarbhai
Common drug induced liver injury in children -dr. harshad devarbhai
 
Indirectly directed hyperbilirubinemia
Indirectly directed hyperbilirubinemiaIndirectly directed hyperbilirubinemia
Indirectly directed hyperbilirubinemia
 
Iron and cancer talk k m mohandas
Iron and cancer talk k m mohandasIron and cancer talk k m mohandas
Iron and cancer talk k m mohandas
 
Not to miss this puo
Not to miss this puoNot to miss this puo
Not to miss this puo
 
Talk: Does hemochromatosis exist in india by Dr. Rakesh Aggarwal
Talk: Does hemochromatosis exist in india  by Dr. Rakesh AggarwalTalk: Does hemochromatosis exist in india  by Dr. Rakesh Aggarwal
Talk: Does hemochromatosis exist in india by Dr. Rakesh Aggarwal
 

Similar to Galactosemia case presentation

A case of recurrent vomiting
A case of recurrent vomitingA case of recurrent vomiting
A case of recurrent vomiting
Atit Ghoda
 
Diabetes mx
Diabetes mxDiabetes mx
Diabetes mx
chricres
 
NNF ready reckoner.pdf
NNF ready reckoner.pdfNNF ready reckoner.pdf
NNF ready reckoner.pdf
KickKick6
 
KETAMINE INDUCED CYSTOPATHY
KETAMINE INDUCED CYSTOPATHYKETAMINE INDUCED CYSTOPATHY
KETAMINE INDUCED CYSTOPATHY
Choying Chen
 
13 Fluid Therapy
13 Fluid Therapy13 Fluid Therapy
13 Fluid Therapy
ghalan
 
A case of nephromegaly
A case of nephromegalyA case of nephromegaly
A case of nephromegaly
Atit Ghoda
 

Similar to Galactosemia case presentation (20)

A case of recurrent vomiting
A case of recurrent vomitingA case of recurrent vomiting
A case of recurrent vomiting
 
Penatalaksanaan gagal nafas pada pasien morbid obesitas dengan penyulit ppok,...
Penatalaksanaan gagal nafas pada pasien morbid obesitas dengan penyulit ppok,...Penatalaksanaan gagal nafas pada pasien morbid obesitas dengan penyulit ppok,...
Penatalaksanaan gagal nafas pada pasien morbid obesitas dengan penyulit ppok,...
 
CASE PRESENTATION ON obstructive jaundice
CASE PRESENTATION ON  obstructive jaundice CASE PRESENTATION ON  obstructive jaundice
CASE PRESENTATION ON obstructive jaundice
 
Case study chronic kidney disease stage v on mhd
Case study  chronic kidney disease stage v on mhdCase study  chronic kidney disease stage v on mhd
Case study chronic kidney disease stage v on mhd
 
Alcoholic Hepatitis & Hepatorenal Syndrome
Alcoholic Hepatitis & Hepatorenal SyndromeAlcoholic Hepatitis & Hepatorenal Syndrome
Alcoholic Hepatitis & Hepatorenal Syndrome
 
Type 2 Diabetes Mellitus
Type 2 Diabetes MellitusType 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
 
case presentation on liver failure
case presentation on liver failurecase presentation on liver failure
case presentation on liver failure
 
Diabetes mx
Diabetes mxDiabetes mx
Diabetes mx
 
Review 1 nutrition_case
Review 1 nutrition_caseReview 1 nutrition_case
Review 1 nutrition_case
 
Pediatric Chronic kidney disease
Pediatric Chronic kidney diseasePediatric Chronic kidney disease
Pediatric Chronic kidney disease
 
NNF ready reckoner.pdf
NNF ready reckoner.pdfNNF ready reckoner.pdf
NNF ready reckoner.pdf
 
Primary hyperoxaluria and the Kidney
Primary hyperoxaluria and the KidneyPrimary hyperoxaluria and the Kidney
Primary hyperoxaluria and the Kidney
 
Sglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesSglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseases
 
KETAMINE INDUCED CYSTOPATHY
KETAMINE INDUCED CYSTOPATHYKETAMINE INDUCED CYSTOPATHY
KETAMINE INDUCED CYSTOPATHY
 
Weekly death round
Weekly death roundWeekly death round
Weekly death round
 
Fluid electrolyte balance
Fluid electrolyte balanceFluid electrolyte balance
Fluid electrolyte balance
 
13 Fluid Therapy
13 Fluid Therapy13 Fluid Therapy
13 Fluid Therapy
 
Cirrhotic Ascites Review
Cirrhotic Ascites Review   Cirrhotic Ascites Review
Cirrhotic Ascites Review
 
Ccp(2) phong qiushi -ori
Ccp(2)   phong qiushi -oriCcp(2)   phong qiushi -ori
Ccp(2) phong qiushi -ori
 
A case of nephromegaly
A case of nephromegalyA case of nephromegaly
A case of nephromegaly
 

More from Sanjeev Kumar

More from Sanjeev Kumar (19)

6 year old with resistant rickets
6 year old with resistant rickets6 year old with resistant rickets
6 year old with resistant rickets
 
Wilson Disease - Beyond the liver and brain…- Dr Ujjal Poddar
Wilson Disease - Beyond the liver and brain…- Dr Ujjal PoddarWilson Disease - Beyond the liver and brain…- Dr Ujjal Poddar
Wilson Disease - Beyond the liver and brain…- Dr Ujjal Poddar
 
Role of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr BanumathiRole of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr Banumathi
 
Key publications on wilson disease in last 3 years
Key publications on wilson disease in last 3 yearsKey publications on wilson disease in last 3 years
Key publications on wilson disease in last 3 years
 
Acute liver failure with hemolysis
Acute liver failure with hemolysis Acute liver failure with hemolysis
Acute liver failure with hemolysis
 
When does one use zinc alone - Dr Vinay Goyal
When does one use zinc alone - Dr Vinay GoyalWhen does one use zinc alone - Dr Vinay Goyal
When does one use zinc alone - Dr Vinay Goyal
 
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...Panel discussion: Developmental, speech, psychiatric and counseling issues - ...
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...
 
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John MatthaiHepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
 
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
 
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...
 
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...
 
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish BavdekarChoice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
 
Copper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas SankaranarayananCopper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas Sankaranarayanan
 
Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?
 
Role of MRI in Wilson disease - Dr Sanjib Sinha
Role of MRI in Wilson disease - Dr Sanjib SinhaRole of MRI in Wilson disease - Dr Sanjib Sinha
Role of MRI in Wilson disease - Dr Sanjib Sinha
 
Complications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi SathiyasekaranComplications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi Sathiyasekaran
 
How do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini MridulaHow do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini Mridula
 
Wilsons disease and hepatitis dr. abhamoni baro
Wilsons disease and hepatitis  dr. abhamoni baroWilsons disease and hepatitis  dr. abhamoni baro
Wilsons disease and hepatitis dr. abhamoni baro
 
Protocol based approach to metabolic liver disease seema alam
Protocol based approach to metabolic liver disease  seema alamProtocol based approach to metabolic liver disease  seema alam
Protocol based approach to metabolic liver disease seema alam
 

Recently uploaded

THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
DR SETH JOTHAM
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Recently uploaded (20)

Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 

Galactosemia case presentation

  • 1. INFANT WITH ACUTE LIVER FAILURE
  • 2. 1.5 months, male, born of non consanguineous marriage, 1st by birth order, birth weight 2.9kg, with h/o: •Yellowish discoloration of eyes and skin since 3days •Abdominal distension with increased frequency of stools since 2days •Fever since 1day
  • 3. ON ENQUIRY: Child apparently alright 3 days back when he developed; • Yellowish discoloration of skin and eyes with high colored urine • No clay colored stools. • Abdominal distension progressively increasing leading to respiratory distress. • Stool frequency 9-12 episodes of green stools/day
  • 4. One episode of malena. • H/o fever, low to moderate grade for one day • No h/o prolonged neonatal jaundice, • No h/o seizures, • No h/o refusal to feed or decreased urinary output. Birth h/o: Uneventful Development h/o : Normal Family & Past history: Not significant
  • 5. GENERAL EXAMINATION Drowsy, afebrile; HR=124/min, pulses well felt; RR=58/min, subcostal retractions+; SPO2=98 on room air BP= 74/46 mmHg, HGT -30 mg/dl Anthropometry: Weight -4.2 kg,10th centile, Length -52cms, 5th centile. Icterus+++,Pallor+, No dysmorphic features. No cataracts. No skin changes.
  • 6. SYSTEMIC EXAMINATION P/A: • Distended, dilated abdominal veins, umbilical hernia+, • Liver 2cm, span 8 cm, firm, sharp margins, nontender. • Spleen 3 cm,firm. • Fluid thrill + RS: Air entry b/l equal CVS: S1S2 normal. CNS : Drowsy, tone, reflexes normal.
  • 7. IMPRESSION Hyperacute liver failure unlikely due to infection alone; D/D: • In born error of metabolism precipitated by an infection. • TORCH Infection – but no h/o antenatal illness or prematurity or IUGR, Normal at birth, until 3 days before admission
  • 8. INITIAL MANAGEMENT • O2 by hood • I.V Fluids to maintain Euglycemia • Blood Cultures collected • 1st dose antibiotics given • Inj Vit K i.v
  • 9. Day1 Day 2 Day 3 Day 4 Day 5 Day 6 Hb(g/dL) 6.8 5.5 7.6 5.1 7.3 7.0 TLC(/cumm 22,200 26,500 14,800 3,600 6,500 5,900 ) Plt(/cumm) 2.4L 2.18 L 1.3 L 40,000 38,000 25,000 s.Bili 38/14 32/23 24/6.1 23/4.5 17.2/5.7 17.6/3.6 T/D(mg/dl) SGOT(IU/L) 306 218 170 94 91 105 SGPT(IU/L) 94 144 100 44 42 40 s.Alb(g/dl) 3.2 2.4 2.6 2.7 PT/PTT 78.7/>2 mins 52.5/>2mins RBS 30 131 28 142 60 62 ABG 7.46/13.5/18. 7.5/ (pH/Hco3/ 6 14.5/ pCO2) Met Acidosis 18.1 +Resp Alk NH3 108 188 134 (micromol/l) LDH(IU/L) 2263 U.Red subs Trace 2+ 3+
  • 10. FURTHER MANAGEMENT For Fulminant hepatic failure Started i.v NAC, i.v L-ornithine, L-aspartate, GDR(glucose delivery rate) increased, PRBC Transfusion, FFP Transfusion. Sensorium deteriorated with worsening LFTs, Hypoglycemia inspite of increasing GDR. Shifted to IPCU
  • 11. Day1 Day 2 Day 3 Day 4 Day 5 Day 6 Hb(g/dL) 6.8 5.5 7.6 5.1 7.3 7.0 TLC(/cumm 22,200 26,500 14,800 3,600 6,500 5,900 ) Plt(/cumm) 2.4L 2.18 L 1.3 L 40,000 38,000 25,000 s.Bili 38/14 32/23 24/6.1 23/4.5 17.2/5.7 17.6/3.6 T/D(mg/dl) SGOT(IU/L) 306 218 170 94 91 105 SGPT(IU/L) 94 144 100 44 42 40 s.Alb(g/dl) 3.2 2.4 2.6 2.7 PT/PTT 78.7/>2 mins 52.5/>2mins RBS 30 131 28 142 60 62 ABG 7.46/13.5/18. 7.5/ (pH/Hco3/ 6 14.5/ pCO2) Met Acidosis 18.1 +Resp Alk NH3 108 188 134 (micromol/l) LDH(IU/L) 2263 U.Red subs Trace 2+ 3+
  • 12. INVESTIGATIONS FOR ETIOLOGICAL DIAGNOSIS •SEPSIS CRP Negative,Blood Cultures negative. •TORCH Titres  Negative •HLH(Hemophagocytic Lympho Histiocytosis ) normal ferritin, bone marrow- no hemophagocytes.
  • 13. Ctd.. • IEM: TYROSINEMIA  AFP 400ng/ml (normal) GALACTOSEMIA  Urine Thin Layer Chromatography galactose+, Total Galactose High, GALT Enzyme level Low.
  • 14. On 9th day— Child developed increasing respiratory distress, Persistent hypoglycemia on GDR of 14, Intubated & ventilated.. Child succumbed to his disease.
  • 15. CONCLUSION 1.5 mnths old infant with • Hyperacute liver failure • Direct hyperbilirubinemia • Persistent hypoglycemia inspite of high GDR. • Metabolic Acidosis • Urine Thin Layer Chromatography - Galactose+, • Total Galactose High, • GALT Enzyme level Low. • Diagnosed as GALACTOSEMIA